Research summary ·
Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025).
Written based on 1 research study on PubMed, searched on 3 Nov 2026.
What was studied
This is a Chinese guideline for children with craniopharyngioma, from 2025. Medical and cancer groups in China developed it. In children, the most common tumor in the sellar region is craniopharyngioma. Most cases are the adamantinomatous type. Fewer are the papillary type. The guideline draws on 398 references.
What they found
The guideline gives advice on diagnosis and surgery. It covers radiotherapy, outlook, follow-up and long-term care. It also covers targeted therapy. Evidence was graded with the GRADE method. Clinical use and expert agreement were also weighed. 35 experts and 6 outside reviewers approved it. They voted on each item.
What it means for patients
The guideline aims to standardize diagnosis and care for these children. It serves as a reference for staff in pediatric neuro-oncology. Key items come with an explained reason. It also says care must address hypothalamus and pituitary problems.
Why it is not certain yet
The abstract gives no study data. The guideline says future trials are needed where evidence is weak. A guideline is only as strong as the evidence and expert agreement behind it.
Source
Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025).
PubMed · PMID 42612900We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Pituitary tumours publications